what is the difference between dpp-4 inhibitors and glp-1 analogs receptor agonist versus inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes The Role of DPP-4 Inhibitors

The Pritikin Plan aligns perfectly with clinical recommendations for GLP-1 drugs for weight loss: Nourishing, water-rich foods Fiber-rich foods Lean protein Eating mindfully Listen to hunger cues Challenging, Pain-free Movement Proven Weight Loss Results The Pritikin Program is built on a foundation of science and medical supervision

This integrative worldview not only enriches scientific understanding but also fosters compassion by reframing addiction as a complex medical condition rather than a moral failing

This combination of physical barriers and psychological stress creates a discouraging cycle, making sustainable weight loss feel almost unattainable

These restrictions may be more limiting for compounded products as compared with FDA-approved products regarding efficacy and safety claims.[21] Congress has granted FDA the authority to ensure that prescription drugs are safe and effective for the uses in the drugs labeling and has given FDA the explicit authority to oversee compounded drugs.[22] Under a 1971 Memorandum of Understanding with the FTC, FDA exercises primary responsibility for prescription drug advertising.[23] While compounded medications have different rules for labels, which are written, printed or graphic matter upon the immediate container of a drug[24], compounded drugs are subject to the same FDCA requirements as prescription drugs for labeling, advertising, and promotion.[25] Finally, the APC has asserted that labeling applies to the physical drug container and ancillary written materials (like package inserts)

And in todays post Id like to share one inspiring example of advocacy

Zhang C, Syed TW, Liu R, Yu J